Psychological Intervention for Type 1 Diabetes
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment ACT1VATE for improving outcomes among adults with Type 1 diabetes?
Is the psychological intervention for Type 1 Diabetes safe for humans?
How is the ACT1VATE treatment different from other treatments for type 1 diabetes?
ACT1VATE is unique because it focuses on reducing emotional distress related to managing type 1 diabetes, which can lead to better blood sugar control and overall health. Unlike traditional treatments that primarily target blood sugar levels directly, this approach addresses the emotional challenges of living with diabetes.23567
What is the purpose of this trial?
This research will compare a psychological intervention ("ACT1VATE") versus diabetes self-management education and support (DSME/S; usual care) in improving clinical, behavioral, psychosocial, process, and cost outcomes among adults with poorly controlled type 1 diabetes (T1D) who are experiencing significant diabetes-related emotional distress and poor glycemic control in a real world, healthcare environment.
Research Team
Athena Philis-Tsimikas, MD
Principal Investigator
Scripps Whittier Diabetes Institute
Addie Fortmann, PhD
Principal Investigator
Scripps Whittier Diabetes Institute
Eligibility Criteria
This trial is for adults with Type 1 Diabetes who feel very stressed about their diabetes and have high blood sugar levels (HbA1c ≥ 8% in the last 90 days). They must speak English or Spanish, be a patient at Scripps Health, and plan to stay in San Diego for the next year. People with severe health or mental issues that could affect participation are not eligible.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either the ACT1VATE psychological intervention or DSME/S usual care via telemedicine
Follow-up
Participants are monitored for changes in glycemic control and emotional distress
Process Evaluation
Evaluation of reach, acceptability, feasibility, adoption, maintenance, and fidelity of the intervention
Treatment Details
Interventions
- ACT1VATE
- DSME/S
Find a Clinic Near You
Who Is Running the Clinical Trial?
Scripps Whittier Diabetes Institute
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator